The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-((5-(3-(tert-Butyl)-1,2,4-oxadiazol-5-yl)-4-((2-hydroxy-1-phenylethyl)amino)pyrimidin-2-yl)amino)-3,3-dimethylisobenzofuran-1(3H)-one ID: ALA4759406
PubChem CID: 142587249
Max Phase: Preclinical
Molecular Formula: C28H30N6O4
Molecular Weight: 514.59
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1noc(-c2cnc(Nc3ccc4c(c3)C(C)(C)OC4=O)nc2N[C@H](CO)c2ccccc2)n1
Standard InChI: InChI=1S/C28H30N6O4/c1-27(2,3)25-33-23(38-34-25)19-14-29-26(32-22(19)31-21(15-35)16-9-7-6-8-10-16)30-17-11-12-18-20(13-17)28(4,5)37-24(18)36/h6-14,21,35H,15H2,1-5H3,(H2,29,30,31,32)/t21-/m1/s1
Standard InChI Key: YPUUKVINJSRXQN-OAQYLSRUSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
27.5574 -17.9263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5562 -18.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2716 -19.1675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9886 -18.7539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9858 -17.9227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2697 -17.5133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2673 -16.6876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.9811 -16.2727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9787 -15.4470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6973 -16.6833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4112 -16.2684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6943 -15.0365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6922 -14.2117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9754 -13.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2592 -14.2196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2649 -15.0431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7042 -19.1656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4186 -18.7517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1309 -19.1638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1233 -17.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4124 -17.9280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8440 -17.9240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8478 -18.7466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6312 -18.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1118 -18.3295 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.6252 -17.6664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8768 -16.8799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4125 -19.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3424 -19.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8468 -17.5140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7603 -16.6929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.9526 -16.5214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5399 -17.2367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0927 -17.8499 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6166 -15.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1018 -15.0992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7955 -15.6811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1986 -15.0492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
8 7 1 1
8 9 1 0
8 10 1 0
10 11 1 0
9 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 9 1 0
4 17 1 0
17 18 1 0
18 19 2 0
19 23 1 0
22 20 1 0
20 21 2 0
21 18 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
26 27 2 0
24 28 1 0
24 29 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 30 1 0
1 30 1 0
32 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 514.59Molecular Weight (Monoisotopic): 514.2329AlogP: 5.12#Rotatable Bonds: 7Polar Surface Area: 135.29Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.25CX Basic pKa: 4.34CX LogP: 5.34CX LogD: 5.34Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -0.67
References 1. Degnan AP,Kumi GK,Allard CW,Araujo EV,Johnson WL,Zimmermann K,Pearce BC,Sheriff S,Futran A,Li X,Locke GA,You D,Morrison J,Parrish KE,Stromko C,Murtaza A,Liu J,Johnson BM,Vite GD,Wittman MD. (2021) Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1., 12 (3): [PMID:33732413 ] [10.1021/acsmedchemlett.0c00660 ]